(VIANEWS) – The NASDAQ ended the session with Tilray (TLRY) jumping 9.69% to $2.10 on Friday while NASDAQ jumped 0.19% to $14,761.56.
Tilray’s last close was $1.91, 62.7% under its 52-week high of $5.12.
About Tilray
Tilray Brands, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It also offers medical and adult-use cannabis products; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. In addition, the company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. and changed its name to Tilray Brands, Inc. in January 2022. Tilray Brands, Inc. is headquartered in Leamington, Canada.
Earnings Per Share
As for profitability, Tilray has a trailing twelve months EPS of $-2.32.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -35.99%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Tilray’s EBITDA is -286.21.
Revenue Growth
Year-on-year quarterly revenue growth grew by 15.5%, now sitting on 650.86M for the twelve trailing months.
Yearly Top and Bottom Value
Tilray’s stock is valued at $2.10 at 02:23 EST, way under its 52-week high of $5.12 and way above its 52-week low of $1.50.
More news about Tilray (TLRY).
